Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind Trial Evaluating the Efficacy, Tolerability and Safety of ESO-101 in Adult Patients With Active Eosinophilic Esophagitis

NCT04849390 is registered in ClinicalTrials.gov with EsoCap AG as lead sponsor.

NCT NCT04849390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04849390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind Trial Evaluating the Efficacy, Tolerability and Safety of ESO-101 in Adult Patients With Active Eosinophilic Esophagitis
Lead sponsor
EsoCap AG
Phase
Phase 2
Overall status
Completed
Start date
June 29, 2021
Completion date
October 9, 2023
Enrollment
43 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis